Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits

Clinica Chimica Acta

Volumn 370, Issue 1-2, 2006, Pages 57-62

  Li, Jie Qi ^a   Zhao, Shui Ping ^b   Li, Quan Zhong ^c   Cai, Yun Chang ^d   Wu, Li Rong ^a   Fang, Ying ^a   Li, Ping ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c GUILIN MEDICAL UNIVERSITY   (China)

^d Department of Cardiology   (China)

Author keywords

Adipose tissue adipocyte; Atherosclerosis; Atorvastatin; Fibrinolysis; Mevalonate; Plasminogen activator inhibitor 1

Indexed keywords

ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MEVALONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADIPOSE TISSUE; ANIMAL FEED; ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; MALE; MEVALONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRROLES; RABBITS; RNA, MESSENGER; TRIGLYCERIDES;

ORYCTOLAGUS CUNICULUS;

EID: 33746092897     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.024     Document Type: Article

References (21)

1. Loskutoff D.J., and Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 18 (1998) 1-6
2. Samad F., and Loskutoff D.J. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med (1996) 568-582
3. Samad F., Schneiderman J., and Loskutoff D. Expression of fibrinolytic genes in tissue from human atherosclerotic aneurysms and from obese mice. Ann N Y Acad Sci 11 (1997) 350-358
4. Oskutoff D.J., Fujisawa K., and Samad F. The fat mouse. A powerful genetic model to study hemostatic gene expression in obesity/NIDDM. Ann N Y Acad Sci 902 (2000) 272-281
5. Zhao S.P., Li J., Xu Z., Wu J., Li Q., and Ye H. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits. Clin Chim Acta 349 (2004) 81-86
6. Son J.W., Koh K.K., Ahn J.Y., et al. Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Int J Cardiol 88 (2003) 77-82
7. Lopez S., Peiretti F., Bonardo B., et al. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152 (2000) 359-366
8. Dangas G., Smith D.A., Unger A.H., et al. Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Thromb Haemost 83 (2000) 688-692
9. Bourcier T., and Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 20 (2000) 556-562
10. Markle R.A., Han J., Summers B.D., et al. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem 90 (2003) 23-32
11. Wiesbauer F., Kaun C., Zorn G., et al. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins. Br J Pharmacol 135 (2002) 284-292
12. Haslinger B., Kleemann R., Toet K.H., et al. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-[alpha]-activated human peritoneal mesothelial cells. Kidney Int 63 (2003) 2065-2074
13. Cabrero A., Alegret M., and Sanchez R.M. Bezafibrate reduces mRNA concentrations of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 50 (2001) 1883-1890
14. Zhang H.H., Kumar S., Barnett A.H., et al. Ceiling culture of mature human adipocdytes: use in studies of adipocyte functions. J Endocrinol 164 (2000) 119-128
15. Watanabe A., Kurabayashi M., Arai M., et al. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells. Cardio Res 51 (2001) 151-159
16. Skurk T., Lee Y.M., and Hauner H. Angiotensin and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension 37 (2001) 1336-1340
17. Fan J.G., Chen L.H., Xu Z.J., et al. Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbit with fatty liver. World J Gastroenterol 7 (2001) 710-712
18. Patrick L., Edith G., and Yasojima K. Expression of Cox-1 and Cox-2 mRNAs in atherosclerotic plaques. Exp Gerontol 37 (2002) 925-929
19. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study Group. Lancet 344 (1994) 1383-1389
20. Sacks F.M., Pfeffer M.A., and Moye L.A. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol concentrations. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
21. Rosenson R.S. Non-lipid-lowering effects of statins on atherosclerosis. Curr Cardiol Rep 1 (1999) 225-232